Stage III Uterine Corpus Leiomyosarcoma AJCC v8

Explore clinical trials studying Stage III Uterine Corpus Leiomyosarcoma AJCC v8. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Uterine Corpus Leiomyosarcoma AJCC v8 trial results

Active, Not Recruiting

NCT03880019

Conditions: Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8, Uterine Corpus Leiomyosarcoma
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Stanford Cancer Institute Palo Alto Palo Alto, California, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

View all 15 locations

Active, Not Recruiting

NCT05432791

Conditions: Locally Advanced Uterine Corpus Leiomyosarcoma, Metastatic Uterine Corpus Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8, +2 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View all 145 locations

Active, Not Recruiting

NCT04200443

Conditions: Leiomyosarcoma, Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

Northwestern University Chicago, Illinois, United States

University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

Washington University School of Medicine St Louis, Missouri, United States